Article info

Original research
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders

Authors

  1. Correspondence to Associate Professor Matteo S Carlino; matteo.carlino{at}sydney.edu.au
View Full Text

Citation

Brown LJ, Weppler A, Bhave P, et al
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders

Publication history

  • Accepted March 14, 2021
  • First published May 7, 2021.
Online issue publication 
February 07, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.